Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Muhammed, Bekir Hacioglu"'
Autor:
Ahmet, Kucukarda, Ali, Gokyer, Ivo, Gokmen, Muhammed, Bekir Hacioglu, Osman, Kostek, Nazmi, Kurt, Derya, Karabulut, Nermin, Tuncbilek, Sernaz, Uzunoglu, Bulent, Erdogan, Irfan, Cicin
Publikováno v:
Journal of B.U.ON. : official journal of the Balkan Union of Oncology. 26(3)
We aimed to assess whether skeletal muscle loss during EGFR thyrosine kinase inhibitor therapy of advance non-small cell lung cancer patients is an independent prognostic factor for progression-free survival (PFS) and overal survival (OS).A total of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::2fd827c318d0a0e85ae829ebce2f5d17
https://pubmed.ncbi.nlm.nih.gov/34268945
https://pubmed.ncbi.nlm.nih.gov/34268945
Autor:
Devrim Cabuk, Hilmi Tozkir, Esma Turkmen, Ahmet Cinkaya, Ilhan Hacibekiroglu, Senem Karabulut, Bulent Erdogan, Irfan Cicin, Hilmi Kodaz, Sernaz Uzunoglu, Ozgur Tanriverdi, Muhammed Bekir Hacioglu
Publikováno v:
Bosnian Journal of Basic Medical Sciences, Vol 16, Iss 4 (2016)
WOS: 000388033500007
PubMed: 27371767
Lung cancer in smokers and non-smokers demonstrates distinct genetic profiles, and cigarette smoking affects epidermal growth factor receptor (EGFR) function and causes secondary EGFR tyrosine kinase re
PubMed: 27371767
Lung cancer in smokers and non-smokers demonstrates distinct genetic profiles, and cigarette smoking affects epidermal growth factor receptor (EGFR) function and causes secondary EGFR tyrosine kinase re
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::35ceb52402b65e74ea6369d0c236e872
https://europepmc.org/articles/PMC5136764/
https://europepmc.org/articles/PMC5136764/
